F. Femia

发表

A series of halogenated heterodimeric inhibitors of prostate specific membrane antigen (PSMA) as radiolabeled probes for targeting prostate cancer.

A. Kozikowski, W. Eckelman, J. Babich, 2009, Journal of medicinal chemistry.

A Gadolinium Chelate for Detection of β-Glucuronidase: A Self-Immolative Approach

T. Meade, F. Femia, Frank J. Femia, 2005 .

Synthesis and Evaluation of a Series of 99mTc(CO)3+ Lisinopril Complexes for In Vivo Imaging of Angiotensin-Converting Enzyme Expression

V. Dilsizian, W. Eckelman, J. Babich, 2008, Journal of Nuclear Medicine.

Molecular imaging of human ACE-1 expression in transgenic rats.

V. Dilsizian, N. Wong, J. Narula, 2012, JACC. Cardiovascular imaging.

Comparison of high-specific-activity ultratrace 123/131I-MIBG and carrier-added 123/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution.

J. Babich, S. Hillier, K. Maresca, 2010, Cancer biotherapy & radiopharmaceuticals.

Synthesis and characterization of a ‘3+2’ {Re(V)O}3+ core complex carrying the ONS/PO donor atom set

J. Zubieta, J. Babich, F. Femia, 2001 .

Schiff base chemistry of the rhenium(V)-oxo core with '3+2' ligand donor sets.

J. Zubieta, J. Babich, F. Femia, 2001, Inorganica chimica acta.

The syntheses and structures of '3+2' and '2+2+1' oxorhenium mixed-ligand complexes employing 8-hydroxy-5-nitroquinoline as the bidentate N,O donor ligand.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Syntheses and structural characterization of rhenium-bis-hydrazinopyrimidine core complexes with thiolate and Schiff base coligands.

J. Zubieta, J. Babich, K. Maresca, 2000, Inorganica chimica acta.

Synthesis and crystal and molecular structure of a tetranuclear cluster based on the rhenium(III)-bisorganohydrazino core: [Re(HNNC(4)H(3)N(2))(NNC(4)H(3)N(2))(OCH(3))(2)](4).

J. Zubieta, J. Babich, K. Maresca, 2000, Inorganica chimica acta.

6-Mercaptomethylpyridine-3-carboxylic acid (MEMNIC): a new reagent for peptide labeling with Tc-99m

A. Fischman, J. Zubieta, J. Babich, 2001 .

on Efficacy, Pharmacokinetics, and Tissue Distribution

J. Babich, S. Hillier, K. Maresca, 2018 .

Novel polar single amino acid chelates for technetium-99m tricarbonyl-based radiopharmaceuticals with enhanced renal clearance: application to octreotide.

W. Eckelman, J. Marquis, J. Babich, 2010, Bioconjugate chemistry.

Spectroscopic and structural studies of complexes of the fac-[Re(N∩N)(CO)3L]n+ type (N∩N=2-(2-pyridyl)benzothiazole; L=Cl, Br, CF3SO3 −, CH3CN)

J. Zubieta, J. Babich, F. Femia, 2001 .

Synthesis, characterization, and biodistribution of a Technetium-99m ‘3+1’ fatty acid derivative. The crystal and molecular structures of a series of oxorhenium model complexes

A. Fischman, J. Zubieta, T. Shoup, 2002 .

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123I-Iobenguane

N. Petry, J. Babich, M. Stabin, 2014, The Journal of Nuclear Medicine.

Phase-1 Clinical Trial Results of High-Specific-Activity Carrier-Free 123 I-Iobenguane

N. Petry, J. Babich, M. Stabin, 2014 .

Mechanistic investigation of beta-galactosidase-activated MR contrast agents.

T. Meade, C. Luchinat, G. Parigi, 2008, Inorganic chemistry.

Synthesis and structural characterization of rhenium(I) tricarbonyl complexes with the bidentate ligands o-(diphenylphosphino)benzaldehyde (P∩O) and o-[(diphenylphosphino)benzylidene]analine (P∩N).

J. Zubieta, J. Babich, F. Femia, 2001, Inorganica chimica acta.

Schiff base chemistry of the {ReO} core: structural characterization of the unusual '3 + 2' complex [ReO(eta-OC(6)H(4)-CH=NC(6)H(4)-2-S)(eta-OC(6)H(4))].

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Structural characterizations of an Re(IV) complex [ReCl4(OPPh3)2] and of an imino species [ReOCl2(PPh3)(η2-OC6H4-2-CHNH)] prepared from the reaction of [ReOCl3(PPh3)2] with salicylaldoxime

J. Zubieta, J. Babich, F. Femia, 2000 .

Investigations of the {ReO}3+ core: A '2 + 2' complex from bidentate and potentially trident ligands: [ReO(η2-HOC6H4-2-CH2NC6H4S)(η2-SC5H4N)(PPh3)]

J. Zubieta, J. Babich, F. Femia, 2000 .

Synthesis and characterization of complexes of the {ReO} core with SNS and S donor ligands.

J. Zubieta, T. Shoup, J. Babich, 2000, Inorganica chimica acta.

Structural systematics of the {ReO}3+ core with ‘3+2’ ligand donor sets

J. Zubieta, J. Babich, F. Femia, 2000 .

Oxorhenium(V) complexes containing tridentate Schiff-base and monothiol coligands.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Cationic complexes of the ‘3+1’ oxorhenium–thiolate family

J. Zubieta, J. Babich, K. Maresca, 2000 .

99mTc-labeled chemotactic peptides: influence of coligand on distribution of molecular species and infection imaging properties. Synthesis and structural characterization of model complexes with the {Re(η2-HNNC5H4N)(η1-NNC5H4N)} core

A. Fischman, J. Zubieta, J. Babich, 2000 .

Synthesis, characterization and crystal structures of mono-, di- and trinuclear rhenium(I) tricarbonyl complexes with 2,3,5,6-tetra(2-pyridyl)pyrazine.

J. Zubieta, J. Babich, F. Femia, 2001, Inorganica chimica acta.

Exploring oxorhenium '3+1' mixed-ligand complexes carrying the S-benzyl-3-[(2-hydroxyphenyl)methylene]dithiocarbazate [ONS]/monothiol [S] donor set: synthesis and characterization.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Rhenium(I) carbonyl complexes of 2,4,6-tris(2-pyridyl)-1,3,5-triazine (TPT). Rhenium(I)-promoted methoxylation of the triazine ring carbon atom in dinuclear rhenium complexes.

J. Zubieta, J. Babich, F. Femia, 2001, Inorganic chemistry.

Synthesis and characterization of oxorhenium(V)–‘3+1’ mixed thiolate [SNS]/[S] and [ONS]/[S] complexes. Crystal and molecular structures of [ReO(η3-SCH2C5H3NCH2S)(η1-C6H4Br-4-S)], [ReO(η3-SCH2C5H3NCH2O)(η1-C6H4X-4-S)] (X=Cl, OMe), [ReO(η3-SCH2C5H3NCH2O)(η1-C6H4OCH3-4-CH2S)] and [ReO(η3-SCH2C5H3NCH2S

J. Zubieta, J. Babich, F. Femia, 2000 .

An unexpected '4+2' [N(3)S]:[NS] rhenium(IV) complex formed upon cleavage of a Re(V) imido bond.

J. Zubieta, J. Babich, F. Femia, 2000, Inorganica chimica acta.

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

Martin G Pomper, William C Eckelman, John W Babich, 2009, Cancer research.

Mechanistic Investigation of β-Galactosidase-Activated MR Contrast Agents

Claudio Luchinat, Giacomo Parigi, Thomas J. Meade, 2008 .

A gadolinium chelate for detection of beta-glucuronidase: a self-immolative approach.

T. Meade, F. Femia, Joseph A. Duimstra, 2005, Journal of the American Chemical Society.